https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/accounts-payable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/accounts-receivable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/accounts-receivable-gross-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/accrued-income-taxes-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/accrued-liabilities-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/accumulated-depreciation https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/adjustment-for-amortization https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/adjustment-of-warrants-granted-for-services https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/advances-on-inventory-purchases https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/allowance-for-doubtful-accounts-receivable-change https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/amended-reports-10-q https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/aoci https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/assets-noncurrent https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/bank-loans https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/basic-shares https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/buildings-and-improvements-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/cash-and-equivalents https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/cash-change https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/cash-flow-breakdown https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/common-stock-value https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/comprehensive-income https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/construction-in-progress-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/contractual-obligation https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/cost-of-goods-sold https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/cover-page-shares-outstanding https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/current-assets https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/current-liabilities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/customer-advances-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/debt-issued https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/debt-repaid https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-revenue-and-credits-noncurrent https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-tax-assets-liabilities-net-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-tax-assets-net https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-accrued-liabilities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-tax-assets-tax-deferred-expense-reserves-and-accruals-allowance-for-doubtful-accounts https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deferred-tax-assets-valuation-allowance-noncurrent https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/deposits-assets-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/depreciation https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/diluted-shares https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/dilutive-shares https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/due-to-related-parties-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/effective-tax-rate https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/eps https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/eps-basic https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/equity-method-investments https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/financing-cash-flow https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-after-year-five https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-next-twelve-months https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-year-five https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-year-four https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-year-three https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-amortization-expense-year-two https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/finite-lived-intangible-assets-net https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/foreign-earnings https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/gain-loss-on-derivative-instruments-net-pretax https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/gain-loss-on-sale-of-property-plant-equipment https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/general-and-administrative-expense https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/gross-profit https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/income-tax https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/income-taxes-paid https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-customer-advances https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-derivative-liabilities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-inventories https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/increase-decrease-in-restricted-cash https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/interest-and-fee-income-loans-and-leases https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/interest-costs-capitalized https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/interest-expense https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/interest-expense-short-term-borrowings https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/interest-income-expense-net https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/interest-income-other https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/interest-paid https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/interest-receivable-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/inventory https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/inventory-adjustments https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/inventory-finished-goods https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/inventory-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/inventory-raw-materials https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/inventory-work-in-process https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/inventory-write-down https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/investing-cash-flow https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/investment-income-interest https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/lease-and-rental-expense https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/liabilities-noncurrent https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/line-of-credit-facility-maximum-borrowing-capacity https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/machinery-and-equipment-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/net-cash-from-financing-activities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/net-cash-from-investing-activities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/net-cash-from-operating-activities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/net-income https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/new-shares-sold https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-2 https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-cash-flow https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-expenses https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-income https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-lease-payments-due https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-lease-payments-due-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-lease-payments-due-thereafter https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-loss-carryforwards https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/operating-loss-carryforwards-valuation-allowance https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/other-income https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/other-inventory https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/other-noncurrent-liabilities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/other-nonoperating-income-expense https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/other-prepaid-expense-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/other-receivables https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/other-receivables-net-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/paid-in-capital-other https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/payments-for-construction-in-process https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/payments-of-financing-costs https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/payments-to-acquire-loans-receivable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/payments-to-acquire-machinery-and-equipment https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/payments-to-acquire-other-property-plant-and-equipment https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/payments-to-fund-longterm-loans-to-related-parties https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/payments-to-suppliers https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/pledged-assets-not-separately-reported-real-estate https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/preferred-shares-facts https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/preferred-stock-shares-authorized https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/preferred-stock-shares-issued https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/preferred-stock-value https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/prepaid-expense-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/prepaid-expense-noncurrent https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/prepaid-taxes https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/pretax-income https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/pretax-income-minority-interest-and-income-loss-from-equity-method-investments https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-bank-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-collection-of-finance-receivables https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-collection-of-loans-receivable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-issuance-of-other-long-term-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-issuance-or-sale-of-equity https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-related-party-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/proceeds-from-short-term-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/property-plant-and-equipment-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/property-plant-and-equipment-other-net https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/property-plant-equipment https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/provision-for-doubtful-accounts https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/public-float https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/real-estate-and-accumulated-depreciation-carrying-amount-of-land https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/repayments-of-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/repayments-of-related-party-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/repayments-of-short-term-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/research-and-development https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/research-and-development-arrangement-with-federal-government-customer-funding-to-offset-costs-incurred https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/retained-earnings https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sales-and-excise-tax-payable-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sales-revenue-goods-net https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-comment-letters-corresp https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-comment-letters-upload https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-10-k https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-10-q https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-10ksb https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-10qsb https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-10sb12g https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-25-nse https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-8-a12b https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-8-k https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-certnas https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-def-14a https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-def-14c https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-ntn-10k https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-ntn-10q https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-pre-14a https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-pre-14c https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-pres14c https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-regdex https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-revoked https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-sb-2 https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/sec-filings-sc-14f1 https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-424b1 https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-effect https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-fwp https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-rw https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/selling-expense https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/shareholders-equity https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/shares-authorized https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/shares-issued https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/shares-issued-for-options-exercised https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/short-term-borrowings https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-award-number-of-shares-authorized https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-award-options-expirations-in-period-average-exercise-price https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-award-rsu-forfeited-in-period https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-award-rsu-grants-in-period https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-award-rsu-nonvested-number https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-award-rsu-vested-in-period https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-based-compensation https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-granted-value-share-based-compensation-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-options-exercisable-number https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-options-expirations-in-period https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-options-outstanding-number https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/stock-options-vested-in-period-fair-value https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/tax-rate-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/tax-rate-reconciliation-nondeductible-expense-share-based-compensation-cost https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/tax-rate-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/tax-rate-reconciliation-tax-settlements-foreign https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/taxes-payable-current https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/total-assets https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/total-liabilities https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/total-liabilities-and-equity https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/total-long-term-debt https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/valuation-allowance-for-impairment-of-recognized-servicing-assets-aggregate-write-downs https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/value-added-tax-receivable https://stock.noler.com/us/stock/skystar-bio-pharmaceutical-co/weighted-average-number-of-shares-issued-basic